BioCom Lab technologies
The OEIP is a substance delivery technology developed at the Laboratory of Organic Electronics at Linköping University. The device utilizes organic electronic polymers and polyelectrolytes to enable liquid-flow-free delivery of precise amounts of charged biomolecules. When voltage is applied, ions are "pumped" into the target region (cells, tissue), and the current through the device corresponds precisely with the number of molecules delivered. OEIPs have been utilized to on cells in vitro, to demonstrate pain therapy, and to reduce epileptic activity in a mouse model. In the BioCom Lab system, OEIPs will be a key actuator technology to provide automated dosage and physiological control.
Advances in sensor technology have recently made it possible to follow health status via wearable technology and Acreo Swedish ICT AB has worked on such wearable sensors for many years. This includes printable electrochemical sensors for health markers, EEG sensors to detect neurological (mal)functioning, heartrate/blood pressure sensors, and inflammations sensor. In the BioCom Lab, we aim for a strategy with broad palette of sensors to increase the probability of predicting, for example, epileptic seizures, and also to show the generic usability of the platform by detecting these multiple parameters.
Body-area networks (BANs), based on traditional Si-chip technology, have been developed in recent years as a solution to extend connectivity to and across the body. BANs use the human body itself as a communication channel with, for instance, our hands as the galvanic or capacitive connectors. BAN technology can be further enabled by body-coupled communication (BCC) networks and is already being explored for monitoring patients’ health status parameters. The BioCom Lab will develop dedicated BAN/BCC components, enabling health-status – and treatment – information to be communicated from sensors and actuators, through the body, and to/from the Internet, e.g., via a smart phone.
Hops, developed by SICS Swedish ICT, is a new next-generation distribution of Apache Hadoop, the world’s most popular platform for the storage and processing of Big Data. Hops’ key innovation is a novel distributed architecture for managing metadata in Hadoop, resulting in a more scalable, faster, and more customizable version of the dominant open-source Hadoop platform. Hops has been designed with special consideration for sensitive Big Data. Hops will form the information back-end for all sensor, actuator, and health-status data generated with BioCom Lab technology. Hops will thus safely enable treatment to be determined "in the cloud", and therapy protocols to be distributed back to the body-area network of components.